Upregulation of MARCKS, particularly phosphorylated MARCKS (phospho-MARCKS) at the phosphorylation site domain (PSD), has recently emerged as both a biomarker and therapeutic target for lung cancer 11, 13, 15, 17, 19, 20, a malignancy etiologically associated with cigarette smoking 2. Here, MARCKS is linked to lung cancer.